Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2003
09/03/2003CN1120019C Insulin preparations containing NaCl
09/03/2003CN1120017C Tendon injure treating spray and its preparation
09/03/2003CN1120016C Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases
09/03/2003CN1120010C Scrophularia capsule and its preparing process
09/03/2003CN1120004C Coated gongyanping tablet in special shape and its making process
09/03/2003CN1120001C Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
09/03/2003CN1120000C Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
09/03/2003CN1119998C Compressed dry-granulation desogestrel tablets
09/03/2003CN1119997C Percutaneous tap preparation containing fentanyl
09/03/2003CN1119993C Amino-phenol acetate, pseudoephedrine, chlorpheniramine maleate and with and without dextromethorphan rotary granulating and coating
09/03/2003CN1119992C Process Ôàí"
09/03/2003CN1119984C Nano-emulsion based on dehydrated sorbitol fatty acid ester and application thereof
09/02/2003US6614831 Mounting arrangement for auxiliary burner or lance
09/02/2003US6613927 Sterile lyophilized ifosfamide and associated methods
09/02/2003US6613807 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs
09/02/2003US6613790 Prodrugs of COX-2 inhibitors
09/02/2003US6613788 Transdermal patch to systemically deliver effective dose of histamine comprising histamine and controlled release preparation which releases drug over period of time sufficient to obtain stable elevated levels in circulating blood
09/02/2003US6613735 Using quaternary ammonium compound
09/02/2003US6613361 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
09/02/2003US6613360 Spray-coated pharmaceutical powder compositions for transdermal administration using a needleless syringe comprise seed particles coated with a pharmaceutical composition, the said coated seed particles having an average size of about 10
09/02/2003US6613358 Contacting an organic solvent with co-dissolved a biocompatible polymer and a hydrophobic ion pair complex of an amphiphilic material and pharmaceutical with a compressed antisolvent fluid
09/02/2003US6613357 For therapy of respiratory congestion related disorders and allergy related disorders; controlled release
09/02/2003US6613356 Medication for weight loss by means of appetite suppression and a method for administering this medication to humans and other mammals. The medication comprises potassium butyrate or closely related chemical compounds, together with chemicals
09/02/2003US6613355 Semi-solid delivery vehicle and pharmaceutical compositions
09/02/2003US6613354 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
09/02/2003US6613353 Pharmaceutical formulations
09/02/2003US6613352 Low-rigidity liposomal formulation
09/02/2003US6613351 Vector including a complex between at least one compound having an amidine polar head of formula where m is 14 and at least one of nucleic acids molecules, polypeptides, glycosylated polypeptides and membrane
09/02/2003US6613350 Electrical apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
09/02/2003US6613349 Bactericides
09/02/2003US6613346 Compressible powder
09/02/2003US6613344 Methods utilizing stinging cells/capsules
09/02/2003US6613332 Oral administration of therapeutic proteins
09/02/2003US6613308 Administering to the respiratory tract a drug at a dose which is at least about two-fold less than the dose required by oral administration.
09/02/2003US6613307 Satisfactory dispersions of salmeterol xinafoate in fluorocarbon, hydrogen-containing fluorocarbon or hydrogen-containing chlorofluorocarbon propellants such as 1,1,1,2-tetrafluoroethane
09/02/2003CA2081709C Controlled release pharmaceutical compositions
08/2003
08/28/2003WO2003070919A1 Antimicrobial composition
08/28/2003WO2003070909A2 Microparticles with adsorbed polypeptide-containing molecules
08/28/2003WO2003070905A2 Electroporation methods for introducing bioactive agents into cells
08/28/2003WO2003070753A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
08/28/2003WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003WO2003070735A2 Components for producing amphoteric liposomes
08/28/2003WO2003070662A1 Decomposable monolithic ceramic materials having an at least bimodal pore distribution and active metal centers located in the pores
08/28/2003WO2003070315A2 Temperature control system for cutaneous photodynamic therapy
08/28/2003WO2003070281A1 Prostaglandin composition for the treatment of erectile dysfunction
08/28/2003WO2003070280A2 Absorption enhancing agent
08/28/2003WO2003070279A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003WO2003070273A1 A bioadhesive agent
08/28/2003WO2003070263A1 Process for producing hydrophobic glycyrrhiza extract with high qualities
08/28/2003WO2003070228A1 Percutaneous absorption type plaster
08/28/2003WO2003070227A1 Taste-masked film-type or wafer-type medicinal preparation
08/28/2003WO2003070226A1 Edible pga coating composition
08/28/2003WO2003070225A1 A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
08/28/2003WO2003070224A1 Rapidly soluble film covering based on polyvinylalcohol-polyether graft copolymers combined with components containing hydroxyl, amide, or ester functions
08/28/2003WO2003070223A1 Sustained release preparations and process for producing the same
08/28/2003WO2003070222A1 Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents
08/28/2003WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
08/28/2003WO2003070219A1 Drug delivery system for the subconjunctival administration of fine grains
08/28/2003WO2003070218A1 Sustained-release ointment for topical administration
08/28/2003WO2003070217A1 Levothyroxine compositions and methods
08/28/2003WO2003070216A1 System for transvaginal drug delivery
08/28/2003WO2003070215A1 Powder inhalation containing cgrp-antagonist bibn4096 and method for the production thereof
08/28/2003WO2003070214A2 Method of automatically populating contact information fields for a new contact added to an electronic contact database
08/28/2003WO2003070213A2 Liquid mucoadhesive pharmaceutical composition
08/28/2003WO2003070194A2 Amino acid and peptide-modified forms of glucocorticoids
08/28/2003WO2003070191A2 Tamper-resistant transdermal opioid delivery devices
08/28/2003WO2003070178A2 Throat spray
08/28/2003WO2003070161A2 Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol
08/28/2003WO2003070156A2 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same
08/28/2003WO2003070155A2 Orally administrable pharmaceutical formulation
08/28/2003WO2003070154A2 Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003070148A1 Granulation process
08/28/2003WO2003070110A1 Drug administration method
08/28/2003WO2003070023A1 Amino acid powder and process for producing the same
08/28/2003WO2003069998A1 Stable compositions comprising tezacitabine
08/28/2003WO2003057359A3 Microparticles and methods for their production
08/28/2003WO2003053158A3 Malleable protein matrix and uses thereof
08/28/2003WO2003047629A3 Treatment of diseases via the skin
08/28/2003WO2003041690A3 Three-dimensional suspension printing of dosage forms
08/28/2003WO2003041683A3 Orodispersible tablets containing fexofenadine
08/28/2003WO2003037297A3 Photosensitizer functionalised nanoparticles
08/28/2003WO2003035045A3 Hard capsules based on polysaccharide and method for the production thereof
08/28/2003WO2003035044A3 Production of starch-gel-based shaped bodies
08/28/2003WO2003035026A3 Polysaccharide-based network and method for the production thereof
08/28/2003WO2003022071A3 Colorant for food and pharmaceuticals
08/28/2003WO2003017998B1 Platinum complexes and their use in cancer treatment
08/28/2003WO2003017990A3 Ophthalmic composition comprising an ascomycin
08/28/2003WO2003015656A3 Oral care substance delivery strip
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003011239A3 Sunscreen composition
08/28/2003WO2003006017A3 Use of certain castanospermine esters in the treatment of influenza virus infections
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002058622A3 Sn-38 lipid complexes and methods of use
08/28/2003WO2002028430A3 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002013786A3 Method of forming microparticles
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003WO2002005800A9 Compositions for sustained release of analgesic agents, and methods of making and using the same
1 ... 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 ... 2991